New study from MD Anderson.
"Long-term outcomes appear similar among high and very high-risk prostate cancer patients deemed eligible for either RP or RT and treated after consultation in a multidisciplinary prostate cancer clinic."
So, to those who are beating themselves up over making the wrong choice - stop it.
Of course, some will say that radiation is so much better today than it was in 2004-2013.
-Patrick
ncbi.nlm.nih.gov/pubmed/310...
BJU Int. 2019 Apr 22. doi: 10.1111/bju.14780. [Epub ahead of print]
Radical Prostatectomy or Radiotherapy for High and Very High Risk Prostate Cancer: A Multidisciplinary Clinic Experience of Patients Eligible for Either Treatment.
Reichard CA1, Hoffman KE2, Tang C2, Williams SB3, Allen PK2, Achim MF1, Kuban DA2, Chapin BF1.
Author information
1
Departments of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.
2
Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
3
Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX.
Abstract
OBJECTIVE:
To compare RP vs. RT with ADT in the setting of high and very high risk patients that were deemed eligible for either therapy and made a treatment choice after consultation in a multidisciplinary prostate cancer clinic (multi-clinic), and to compare the multi-clinic patient outcomes to a matched SEER cohort.
SUBJECTS AND METHODS:
Prospectively collected, retrospective study comparing RP (n=231) versus RT+ADT (n=73) from 2004-2013. Biochemical recurrence (BCR), Local recurrence, Distant metastasis failure, and overall survival (OS) were calculated for each treatment group overall and according to NCCN risk strata. A propensity score matched comparison with a SEER cohort was performed for overall survival.
RESULTS:
There was no difference in local recurrence (HR 2.7; 95%CI 1.0-7.9, p=0.06), distant metastasis failure (HR 2.5; 95%CI 0.8-7.8, p=0.1) and overall survival (HR 1.35; 0.4-4.8, p=0.6) between patients undergoing RP versus RT+ADT. Patients treated via the multi-disciplinary clinic survived on average 16.9 months (95%CI 13.1-20.8) longer than those in the SEER matched cohort.
CONCLUSIONS:
Long-term outcomes appear similar among high and very high-risk prostate cancer patients deemed eligible for either RP or RT and treated after consultation in a multidisciplinary prostate cancer clinic. Outcomes of the multi-clinic patients were superior to those of the matched SEER cohort. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.
KEYWORDS:
high risk; multidisciplinary; radical prostatectomy; radiotherapy; robotic
PMID: 31009137 DOI: 10.1111/bju.14780